{"hands_on_practices": [{"introduction": "Our modern understanding of mitochondrial protein import is built upon a foundation of elegant in vitro experiments. This exercise challenges you to step into the shoes of a researcher and interpret a classic series of biochemical assays. By analyzing the results of protease protection, energy dependence, and carbonate extraction experiments [@problem_id:2960675], you will develop the critical skill of integrating multiple lines of evidence to deduce a protein's import pathway, final sub-mitochondrial location, and membrane topology.", "problem": "A cell-free translation system is used to synthesize a radiolabeled mitochondrial precursor protein, *pX*, in the presence of L-[${}^{35}$S]methionine. Isolated, respiration-competent mitochondria are incubated with *pX* at $25\\,^{\\circ}\\mathrm{C}$ for $30$ minutes under either energized conditions (substrates present; membrane potential across the inner membrane maintained) or de-energized conditions (valinomycin, antimycin A, and oligomycin added to dissipate the membrane potential and block respiration). After incubation, samples are treated as indicated and analyzed by denaturing electrophoresis and autoradiography. The following observations are made:\n\n1. Under energized conditions, a faster-migrating band of approximately $42\\,\\mathrm{kDa}$ accumulates; the input precursor band is approximately $55\\,\\mathrm{kDa}$. Under de-energized conditions, only the $55\\,\\mathrm{kDa}$ band is detected, and it is quantitatively sensitive to exogenously added protease in the absence of detergent.\n\n2. After import under energized conditions, intact mitochondria are treated with trypsin at $0.1\\,\\mathrm{mg/mL}$ for $30$ minutes at $4\\,^{\\circ}\\mathrm{C}$. The $42\\,\\mathrm{kDa}$ band is protease-resistant. If, prior to trypsin, mitochondria are converted to mitoplasts by hypo-osmotic swelling (outer membrane ruptured, inner membrane intact), trypsin converts the $42\\,\\mathrm{kDa}$ band to a protected fragment of approximately $35\\,\\mathrm{kDa}$. This fragment is recognized by an antibody to the N-terminus of *pX* but not by an antibody to the C-terminus. If detergent is added before trypsin, no radiolabeled fragments remain.\n\n3. After import under energized conditions, mitochondria are subjected to alkaline carbonate extraction at $pH\\,11.5$ and centrifuged at $100{,}000\\times g$ for $30$ minutes at $4\\,^{\\circ}\\mathrm{C}$. The radiolabeled *pX* partitions predominantly into the pellet. In parallel controls, a known soluble matrix enzyme partitions to the supernatant, and a known inner membrane transporter partitions to the pellet.\n\nAssume the following foundational principles:\n- Proteases do not cross intact biological membranes; they digest only protein regions exposed to the solution they are added to.\n- Removal of an N-terminal mitochondrial targeting presequence by the matrix processing peptidase yields a faster-migrating mature species.\n- The translocation of presequence-containing substrates across the inner membrane via the Translocase of the Inner Membrane $23$ (TIM$23$) complex requires the electrical component of the proton motive force (membrane potential) across the inner membrane.\n- Alkaline carbonate at $pH\\,11$–$12$ strips peripherally associated membrane proteins, while integral membrane proteins remain associated with membranes and pellet upon ultracentrifugation.\n\nWhich interpretation best integrates all the data to describe the membrane insertion and topology of *pX* after import?\n\nA. *pX* is a single-pass inner membrane protein that uses a stop-transfer mechanism via Translocase of the Outer Membrane (TOM)/TIM$23$; its N-terminus resides in the matrix and its C-terminus in the intermembrane space, and it is an integral membrane protein.\n\nB. *pX* is a soluble matrix protein that completely translocates into the matrix; the protected fragment after mitoplast protease treatment reflects incomplete digestion due to steric hindrance.\n\nC. *pX* is a peripherally associated intermembrane space protein bound to the inner membrane; its association is maintained at physiological $pH$ but disrupted by alkaline carbonate.\n\nD. *pX* is an outer membrane $\\beta$-barrel protein assembled via the Sorting and Assembly Machinery (SAM); the observed protease protection in intact mitochondria indicates insertion into the outer membrane.\n\nE. *pX* is a single-pass inner membrane protein with its N-terminus in the intermembrane space and its C-terminus in the matrix, inserted via a post-import pathway independent of membrane potential.", "solution": "The problem statement must first be validated for scientific and logical consistency before any attempt at a solution is made.\n\n**Step 1: Extraction of Givens**\n- **Protein Synthesis:** A mitochondrial precursor protein, designated $*pX*$, is synthesized in vitro and radiolabeled with $L-[{}^{35}S]\\text{methionine}$.\n- **Precursor Size:** The precursor, $*pX*$, has a mass of approximately $55\\,\\mathrm{kDa}$.\n- **Experiment 1: Import Conditions**\n    - Isolated, respiration-competent mitochondria are incubated with $*pX*$ at $25\\,^{\\circ}\\mathrm{C}$ for $30\\,\\text{minutes}$.\n    - **Energized:** With substrates and inner membrane potential ($\\Delta\\psi$). Result: A band of $\\approx 42\\,\\mathrm{kDa}$ accumulates.\n    - **De-energized:** With valinomycin, antimycin A, and oligomycin (dissipates $\\Delta\\psi$, blocks respiration). Result: Only the $55\\,\\mathrm{kDa}$ band is detected. This band is sensitive to exogenously added protease when no detergent is present.\n- **Experiment 2: Protease Protection Assay**\n    - After import under energized conditions:\n    - **Intact Mitochondria + Trypsin:** The $42\\,\\mathrm{kDa}$ band is resistant to trypsin ($0.1\\,\\mathrm{mg/mL}$, $30\\,\\text{min}$, $4\\,^{\\circ}\\mathrm{C}$).\n    - **Mitoplasts + Trypsin:** Mitochondria are converted to mitoplasts (ruptured outer membrane, intact inner membrane). Subsequent trypsin treatment converts the $42\\,\\mathrm{kDa}$ band to a protected fragment of $\\approx 35\\,\\mathrm{kDa}$.\n    - **Antibody Probing:** The $35\\,\\mathrm{kDa}$ fragment is recognized by an antibody against the N-terminus of $*pX*$, but not by an antibody against the C-terminus.\n    - **Detergent Control:** If detergent is added before trypsin, no radiolabeled fragments remain.\n- **Experiment 3: Alkaline Carbonate Extraction**\n    - After import under energized conditions, mitochondria are treated with alkaline carbonate ($pH\\,11.5$) and subjected to ultracentrifugation ($100{,}000\\times g$).\n    - **Result:** The radiolabeled protein partitions predominantly into the pellet.\n    - **Controls:** A known soluble matrix protein partitions to the supernatant; a known inner membrane transporter partitions to the pellet.\n- **Assumed Principles:**\n    1. Proteases do not cross intact biological membranes.\n    2. N-terminal presequence cleavage by matrix processing peptidase (MPP) results in a faster-migrating (smaller) mature protein.\n    3. Translocation via the TIM$23$ complex requires the inner membrane potential.\n    4. Alkaline carbonate extraction at high $pH$ strips peripheral proteins from membranes, whereas integral membrane proteins pellet with the membrane fraction.\n\n**Step 2: Validation of Problem Statement**\nThe problem is scientifically and logically sound. It describes a set of classical, well-defined experiments used in molecular cell biology to determine the import pathway, subcellular localization, membrane topology, and nature of membrane association for a mitochondrial protein. The provided reagents (valinomycin, antimycin A), techniques (protease protection assays with intact mitochondria and mitoplasts, alkaline carbonate extraction), and observations are all standard and consistent with established principles of mitochondrial biology. The data are internally consistent and provide sufficient, non-contradictory information to deduce a unique interpretation. The problem is well-posed, objective, and scientifically grounded.\n\n**Verdict: The problem is valid.**\n\n**Derivation of Solution**\nThe comprehensive interpretation of the protein $*pX*$ requires a systematic synthesis of all three experimental observations.\n\n1.  **Analysis of Observation 1 (Energy Dependence and Processing):**\n    - The precursor protein $*pX*$ has a mass of $55\\,\\mathrm{kDa}$. Upon incubation with energized mitochondria, a smaller species of $42\\,\\mathrm{kDa}$ appears. This mass decrease of $13\\,\\mathrm{kDa}$ ($55-42=13$) is consistent with the cleavage of an N-terminal mitochondrial targeting presequence by the matrix processing peptidase (MPP), as stated in the assumed principles.\n    - Import and processing occur only under energized conditions, where the inner membrane potential ($\\Delta\\psi$) is maintained. Import is abolished under de-energized conditions. This energy requirement, specifically the dependence on $\\Delta\\psi$, is a hallmark of protein import through the Translocase of the Inner Membrane $23$ (TIM$23$) complex.\n    - Under de-energized conditions, the $55\\,\\mathrm{kDa}$ precursor remains sensitive to external protease, confirming it has not crossed the outer mitochondrial membrane and is exposed on the mitochondrial surface.\n\n2.  **Analysis of Observation 2 (Sub-mitochondrial Localization and Topology):**\n    - **Intact Mitochondria:** The mature $42\\,\\mathrm{kDa}$ protein is resistant to external trypsin. This confirms that it has been successfully imported across the outer membrane and is located in a protease-inaccessible compartment: the intermembrane space (IMS), the inner membrane (IM), or the matrix.\n    - **Mitoplasts:** The outer membrane is ruptured, exposing the IMS and the outer face of the inner membrane to trypsin. In this state, the $42\\,\\mathrm{kDa}$ protein is digested to a smaller, protected fragment of $35\\,\\mathrm{kDa}$. This is a critical finding. It demonstrates that the protein is not a soluble matrix or IMS protein. A soluble matrix protein would remain fully protected ($42\\,\\mathrm{kDa}$), and a soluble IMS protein would be fully digested. The result indicates that a portion of the protein ($42 - 35 = 7\\,\\mathrm{kDa}$) is exposed in the IMS, while the larger portion ($35\\,\\mathrm{kDa}$) is protected from digestion because it is located across the intact inner membrane, i.e., in the mitochondrial matrix. Therefore, the protein must be a transmembrane protein spanning the inner membrane.\n    - **Topology:** The protected $35\\,\\mathrm{kDa}$ fragment is recognized by an antibody specific to the N-terminus. This proves that the N-terminus of the mature protein is located within the matrix. Consequently, the C-terminal portion must be the part that is exposed in the IMS and digested by trypsin. This establishes the topology as N-terminus(matrix) - C-terminus(IMS).\n    - **Detergent Control:** Digestion of all fragments in the presence of detergent confirms that the observed protection is indeed conferred by the integrity of the inner membrane barrier.\n\n3.  **Analysis of Observation 3 (Nature of Membrane Association):**\n    - The mature protein pellets upon alkaline carbonate extraction and ultracentrifugation. This behavior is identical to the known integral inner membrane transporter control and opposite to the soluble matrix protein control, which remains in the supernatant.\n    - According to the provided principles, this result unequivocally demonstrates that the mature protein is an **integral membrane protein**, deeply embedded in the lipid bilayer, and not a peripheral membrane protein that is merely associated with the membrane surface.\n\n**Synthesis and Conclusion:**\nCombining all evidence: $*pX*$ is a precursor protein targeted to the mitochondrion via an N-terminal presequence. It is imported through the TOM/TIM$23$ pathway in a $\\Delta\\psi$-dependent manner. In the matrix, its presequence is cleaved. Translocation across the inner membrane is then arrested by a stop-transfer sequence, causing the protein to be laterally integrated into the inner membrane. The final product is a $42\\,\\mathrm{kDa}$ integral, single-pass inner membrane protein with its N-terminus in the matrix and its C-terminus in the intermembrane space. This entire process is a classic example of a stop-transfer mechanism at the TIM$23$ complex.\n\n**Evaluation of Options**\n\n**A. *pX* is a single-pass inner membrane protein that uses a stop-transfer mechanism via Translocase of the Outer Membrane (TOM)/TIM$23$; its N-terminus resides in the matrix and its C-terminus in the intermembrane space, and it is an integral membrane protein.**\n- This statement is fully consistent with every piece of data. It correctly identifies the protein type (integral inner membrane), the import pathway (TOM/TIM$23$, implied by $\\Delta\\psi$ dependence), the resulting topology (N-matrix, C-IMS), and the underlying mechanism (stop-transfer).\n- **Verdict: Correct.**\n\n**B. *pX* is a soluble matrix protein that completely translocates into the matrix; the protected fragment after mitoplast protease treatment reflects incomplete digestion due to steric hindrance.**\n- This is incorrect. A soluble matrix protein would remain in the supernatant during alkaline carbonate extraction (contradicts Observation 3) and would be completely protected from trypsin in mitoplasts (contradicts Observation 2). The \"steric hindrance\" argument is a weak and unsubstantiated claim against the clear evidence of partial digestion.\n- **Verdict: Incorrect.**\n\n**C. *pX* is a peripherally associated intermembrane space protein bound to the inner membrane; its association is maintained at physiological pH but disrupted by alkaline carbonate.**\n- This is incorrect. A peripherally associated protein would be stripped from the membrane by alkaline carbonate and found in the supernatant, not the pellet (contradicts Observation 3). Furthermore, a protein located entirely in the IMS would be completely digested upon mitoplast formation and trypsin treatment (contradicts Observation 2).\n- **Verdict: Incorrect.**\n\n**D. *pX* is an outer membrane β-barrel protein assembled via the Sorting and Assembly Machinery (SAM); the observed protease protection in intact mitochondria indicates insertion into the outer membrane.**\n- This is incorrect. Import of $\\beta$-barrel proteins via the SAM complex is not dependent on the inner membrane potential, $\\Delta\\psi$ (contradicts Observation 1). The protein is also shown to span the inner membrane, not the outer membrane (contradicts Observation 2).\n- **Verdict: Incorrect.**\n\n**E. *pX* is a single-pass inner membrane protein with its N-terminus in the intermembrane space and its C-terminus in the matrix, inserted via a post-import pathway independent of membrane potential.**\n- This is incorrect. It states the wrong topology; the antibody data clearly place the N-terminus in the matrix (contradicts Observation 2). It also incorrectly claims the import is independent of membrane potential (contradicts Observation 1).\n- **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "2960675"}, {"introduction": "Beyond analyzing how import works, a key challenge in molecular biology is to engineer proteins for desired outcomes. This problem moves from observation to design, exploring the delicate balance between protein stability, import efficiency, and biological function [@problem_id:2960698]. You will quantitatively evaluate several mutational strategies, forcing you to weigh the trade-offs between accelerating import by destabilizing a protein and the risk of compromising its post-import catalytic activity, a common challenge in synthetic biology and therapeutic protein design.", "problem": "A mitochondrial matrix enzyme, MtxA, is nuclear encoded and imported post-translationally via the Translocase of the Outer Membrane (TOM) and Translocase of the Inner Membrane 23 (TIM23) machineries. MtxA bears an N-terminal, amphipathic, positively charged presequence and is otherwise a very stable homodimer. In vitro import assays at $25^\\circ\\mathrm{C}$ show a slow import half-time of approximately $40$ minutes under conditions where the unfolding of cytosolic MtxA prior to or during engagement with TOM/TIM23 is rate-limiting. You are tasked with designing a single-site or localized substitution that destabilizes the fold to accelerate import, while retaining post-import catalytic performance in the mitochondrial matrix.\n\nAssume the following well-tested facts and definitions:\n- Proteins traverse TOM/TIM23 largely in an unfolded state; when unfolding is rate-limiting, the import rate is proportional to the unfolding rate constant $k_{\\mathrm{unf}}$.\n- Two-state unfolding kinetics with an Eyring-like barrier apply: $k_{\\mathrm{unf}} = k_0 \\exp\\left(-\\Delta G^{\\ddagger}_{\\mathrm{unf}}/RT\\right)$, where $k_0$ is a pre-exponential factor, $R$ is the gas constant, and $T$ is absolute temperature.\n- For a large class of single-site destabilizing mutations, the unfolding barrier height obeys a linear free-energy relationship with the folding free energy: $\\Delta G^{\\ddagger}_{\\mathrm{unf}} = a - b\\,\\Delta G_{\\mathrm{fold}}$, with $b>0$. Thus, making $\\Delta G_{\\mathrm{fold}}$ less negative (destabilization) lowers $\\Delta G^{\\ddagger}_{\\mathrm{unf}}$ and increases $k_{\\mathrm{unf}}$.\n- The inner-membrane membrane potential $\\Delta \\psi$ exerts an electrophoretic pull on positively charged presequences; reducing positive charge in the presequence reduces the TIM23 translocation component of import.\n- Post-import catalytic efficiency is defined here as the product of the Michaelis-Menten catalytic efficiency $k_{\\mathrm{cat}}/K_M$ and the fraction of enzyme molecules in the active quaternary state (the dimer, with monomers assumed inactive). For a dimerization equilibrium $2\\mathrm{M} \\rightleftharpoons \\mathrm{D}$ with dissociation constant $K_d = [\\mathrm{M}]^2/[\\mathrm{D}]$ and total subunit concentration $C_T = [\\mathrm{M}] + 2[\\mathrm{D}]$, the fraction of subunits in dimers is $f_{\\mathrm{D,sub}} = 2[\\mathrm{D}]/C_T$.\n\nGiven constants and baseline properties at $T = 298\\,\\mathrm{K}$:\n- $R = 1.987\\times 10^{-3}\\,\\mathrm{kcal\\,mol^{-1}\\,K^{-1}}$.\n- $k_0 = 1.0\\times 10^{6}\\,\\mathrm{s^{-1}}$.\n- $a = 9.0\\,\\mathrm{kcal\\,mol^{-1}}$ and $b = 0.333$ (dimensionless).\n- Wild-type folding free energy $\\Delta G_{\\mathrm{fold}} = -12.0\\,\\mathrm{kcal\\,mol^{-1}}$ at $298\\,\\mathrm{K}$. Under these conditions, the observed $40$ minute import half-time is consistent with unfolding being rate-limiting.\n- Wild-type dimer dissociation constant $K_d^{\\mathrm{WT}} = 1.0\\times 10^{-8}\\,\\mathrm{M}$ (essentially fully dimeric under mitochondrial matrix conditions; monomer is inactive).\n- Mitochondrial matrix total enzyme subunit concentration after import is $C_T = 5.0\\times 10^{-6}\\,\\mathrm{M}$.\n\nYou are considering four alternative designs, each affecting stability and/or function as indicated (all substitutions avoid the presequence except where stated):\n\nA. Introduce a proline in a noncatalytic internal helix (H3→H3P) that partially unwinds the helix: predicted $\\Delta\\Delta G_{\\mathrm{fold}} = +3.0\\,\\mathrm{kcal\\,mol^{-1}}$; $k_{\\mathrm{cat}}$ reduced by $10\\%$; $K_M$ unchanged; quaternary structure unaffected; presequence unchanged.\n\nB. Replace two buried leucines with alanines at the dimer interface (L→A x2): predicted $\\Delta\\Delta G_{\\mathrm{fold}} = +1.5\\,\\mathrm{kcal\\,mol^{-1}}$; $k_{\\mathrm{cat}}$ and $K_M$ unchanged; dimer dissociation constant increases to $K_d = 1.0\\times 10^{-6}\\,\\mathrm{M}$; presequence unchanged.\n\nC. Neutralize two lysines in the presequence (K→A x2): presequence net charge reduced by $+2$; $\\Delta\\Delta G_{\\mathrm{fold}} \\approx 0$ for the folded domain; $k_{\\mathrm{cat}}$ and $K_M$ unchanged; quaternary structure unaffected.\n\nD. Introduce a glycine into an active-site loop (L→G) that increases local flexibility: predicted $\\Delta\\Delta G_{\\mathrm{fold}} = +2.0\\,\\mathrm{kcal\\,mol^{-1}}$; $k_{\\mathrm{cat}}$ unchanged; $K_M$ increases $5$-fold; quaternary structure unaffected; presequence unchanged.\n\nGoal: Choose the single option that best satisfies both of the following design criteria simultaneously:\n1) Achieves at least a $3$-fold acceleration in import (i.e., reduces the import half-time by at least a factor of $3$) by increasing $k_{\\mathrm{unf}}$ under the unfolding-limited regime.\n2) Retains at least $80\\%$ of wild-type post-import catalytic efficiency under the given matrix conditions, using the definition above.\n\nWhich option best meets both criteria?\n\nChoices:\nA. H3→H3P as described.\nB. L→A x2 at the dimer interface as described.\nC. K→A x2 in the presequence as described.\nD. L→G in an active-site loop as described.", "solution": "The problem requires an evaluation of four potential mutations to the protein MtxA, with the goal of selecting the one that simultaneously accelerates mitochondrial import and preserves catalytic function. The validity of the problem statement is confirmed; it is scientifically sound, internally consistent, and provides all necessary parameters for a quantitative analysis. We will proceed by evaluating each mutation against the two specified design criteria.\n\nThe analysis is based on the following governing principles and equations provided in the problem statement.\nThe temperature is $T = 298\\,\\mathrm{K}$, and the gas constant is $R = 1.987 \\times 10^{-3}\\,\\mathrm{kcal\\,mol^{-1}\\,K^{-1}}$, which gives $RT \\approx 0.592\\,\\mathrm{kcal\\,mol^{-1}}$.\n\n**Criterion 1: Import Acceleration**\nThe import rate is proportional to the unfolding rate constant, $k_{\\mathrm{unf}}$, which is given by the Eyring-like equation:\n$$k_{\\mathrm{unf}} = k_0 \\exp\\left(-\\frac{\\Delta G^{\\ddagger}_{\\mathrm{unf}}}{RT}\\right)$$\nThe unfolding activation energy, $\\Delta G^{\\ddagger}_{\\mathrm{unf}}$, is related to the protein's thermodynamic stability, $\\Delta G_{\\mathrm{fold}}$, by a linear free-energy relationship:\n$$\\Delta G^{\\ddagger}_{\\mathrm{unf}} = a - b\\,\\Delta G_{\\mathrm{fold}}$$\nwhere $a = 9.0\\,\\mathrm{kcal\\,mol^{-1}}$ and $b = 0.333$.\nA mutation changes the folding free energy by $\\Delta\\Delta G_{\\mathrm{fold}} = \\Delta G_{\\mathrm{fold}}^{\\mathrm{mut}} - \\Delta G_{\\mathrm{fold}}^{\\mathrm{WT}}$. The corresponding change in the unfolding activation energy is:\n$$\\Delta\\Delta G^{\\ddagger}_{\\mathrm{unf}} = \\Delta G^{\\ddagger, \\mathrm{mut}}_{\\mathrm{unf}} - \\Delta G^{\\ddagger, \\mathrm{WT}}_{\\mathrm{unf}} = -b(\\Delta G_{\\mathrm{fold}}^{\\mathrm{mut}} - \\Delta G_{\\mathrm{fold}}^{\\mathrm{WT}}) = -b\\,\\Delta\\Delta G_{\\mathrm{fold}}$$\nThe import acceleration factor is the ratio of the mutant's unfolding rate constant to the wild-type's:\n$$\\frac{k_{\\mathrm{unf}}^{\\mathrm{mut}}}{k_{\\mathrm{unf}}^{\\mathrm{WT}}} = \\frac{\\exp\\left(-\\Delta G^{\\ddagger, \\mathrm{mut}}_{\\mathrm{unf}}/RT\\right)}{\\exp\\left(-\\Delta G^{\\ddagger, \\mathrm{WT}}_{\\mathrm{unf}}/RT\\right)} = \\exp\\left(-\\frac{\\Delta\\Delta G^{\\ddagger}_{\\mathrm{unf}}}{RT}\\right) = \\exp\\left(\\frac{b\\,\\Delta\\Delta G_{\\mathrm{fold}}}{RT}\\right)$$\nThe criterion requires at least a $3$-fold acceleration, so we must have:\n$$\\exp\\left(\\frac{b\\,\\Delta\\Delta G_{\\mathrm{fold}}}{RT}\\right) \\ge 3$$\nSubstituting the given values:\n$$\\exp\\left(\\frac{0.333 \\times \\Delta\\Delta G_{\\mathrm{fold}}}{0.592\\,\\mathrm{kcal\\,mol^{-1}}}\\right) \\ge 3$$\n$$\\exp(0.5625 \\times \\Delta\\Delta G_{\\mathrm{fold}}/\\mathrm{kcal\\,mol^{-1}}) \\ge 3$$\nTo satisfy this, the destabilization energy $\\Delta\\Delta G_{\\mathrm{fold}}$ must be:\n$$\\Delta\\Delta G_{\\mathrm{fold}} \\ge \\frac{\\ln(3)}{0.5625} \\approx \\frac{1.0986}{0.5625} \\approx 1.953\\,\\mathrm{kcal\\,mol^{-1}}$$\n\n**Criterion 2: Post-Import Catalytic Efficiency**\nThe catalytic efficiency is defined as $\\text{Efficiency} = (k_{\\mathrm{cat}}/K_M) \\times f_{\\mathrm{D,sub}}$, where $f_{\\mathrm{D,sub}}$ is the fraction of protein subunits in the active dimeric state. The criterion requires retention of at least $80\\%$ of the wild-type efficiency:\n$$\\frac{\\text{Efficiency}^{\\mathrm{mut}}}{\\text{Efficiency}^{\\mathrm{WT}}} = \\frac{(k_{\\mathrm{cat}}^{\\mathrm{mut}}/K_M^{\\mathrm{mut}})}{(k_{\\mathrm{cat}}^{\\mathrm{WT}}/K_M^{\\mathrm{WT}})} \\times \\frac{f_{\\mathrm{D,sub}}^{\\mathrm{mut}}}{f_{\\mathrm{D,sub}}^{\\mathrm{WT}}} \\ge 0.80$$\nThe fraction of subunits in dimers, $f_{\\mathrm{D,sub}} = 2[\\mathrm{D}]/C_T$, is found by solving the dimerization equilibrium $2\\mathrm{M} \\rightleftharpoons \\mathrm{D}$ for a total subunit concentration $C_T = [\\mathrm{M}] + 2[\\mathrm{D}]$ and dissociation constant $K_d = [\\mathrm{M}]^2/[\\mathrm{D}]$. The solution to the resulting quadratic equation for the dimer concentration $[\\mathrm{D}]$ gives:\n$$f_{\\mathrm{D,sub}} = \\frac{2[\\mathrm{D}]}{C_T} = \\frac{(4C_T + K_d) - \\sqrt{8C_T K_d + K_d^2}}{4C_T}$$\n\nFirst, we calculate the baseline value for the wild-type protein.\nGiven $C_T = 5.0 \\times 10^{-6}\\,\\mathrm{M}$ and $K_d^{\\mathrm{WT}} = 1.0 \\times 10^{-8}\\,\\mathrm{M}$.\n$$f_{\\mathrm{D,sub}}^{\\mathrm{WT}} = \\frac{(4(5.0 \\times 10^{-6}) + 1.0 \\times 10^{-8}) - \\sqrt{8(5.0 \\times 10^{-6})(1.0 \\times 10^{-8}) + (1.0 \\times 10^{-8})^2}}{4(5.0 \\times 10^{-6})}$$\n$$f_{\\mathrm{D,sub}}^{\\mathrm{WT}} = \\frac{(2.0 \\times 10^{-5} + 0.01 \\times 10^{-6}) - \\sqrt{4.0 \\times 10^{-13} + 1.0 \\times 10^{-16}}}{2.0 \\times 10^{-5}}$$\n$$f_{\\mathrm{D,sub}}^{\\mathrm{WT}} = \\frac{2.001 \\times 10^{-5} - \\sqrt{4.0001 \\times 10^{-13}}}{2.0 \\times 10^{-5}} = \\frac{2.001 \\times 10^{-5} - 6.325 \\times 10^{-7}}{2.0 \\times 10^{-5}} \\approx \\frac{1.9378 \\times 10^{-5}}{2.0 \\times 10^{-5}} \\approx 0.9689$$\nSo, the wild-type protein is approximately $96.9\\%$ dimeric. Now we evaluate each option.\n\n**Option A: H3→H3P**\n1.  **Import Acceleration**: $\\Delta\\Delta G_{\\mathrm{fold}} = +3.0\\,\\mathrm{kcal\\,mol^{-1}}$. Since $3.0 > 1.953$, **Criterion 1 is met**.\n    The acceleration factor is $\\exp(0.5625 \\times 3.0) = \\exp(1.6875) \\approx 5.41$. The import is accelerated over $5$-fold.\n2.  **Catalytic Efficiency**: $k_{\\mathrm{cat}}^{\\mathrm{A}} = 0.9 \\times k_{\\mathrm{cat}}^{\\mathrm{WT}}$, $K_M^{\\mathrm{A}} = K_M^{\\mathrm{WT}}$, and $K_d^{\\mathrm{A}} = K_d^{\\mathrm{WT}}$.\n    The ratio of enzymatic efficiencies is $(k_{\\mathrm{cat}}^{\\mathrm{A}}/K_M^{\\mathrm{A}}) / (k_{\\mathrm{cat}}^{\\mathrm{WT}}/K_M^{\\mathrm{WT}}) = 0.9$.\n    Since $K_d$ is unchanged, $f_{\\mathrm{D,sub}}^{\\mathrm{A}} = f_{\\mathrm{D,sub}}^{\\mathrm{WT}}$.\n    The overall efficiency retention is $0.9 \\times 1.0 = 0.9$. Since $0.9 \\ge 0.8$, **Criterion 2 is met**.\n**Verdict for A**: **Correct**. This option satisfies both design criteria.\n\n**Option B: L→A x2 at dimer interface**\n1.  **Import Acceleration**: $\\Delta\\Delta G_{\\mathrm{fold}} = +1.5\\,\\mathrm{kcal\\,mol^{-1}}$. Since $1.5  1.953$, **Criterion 1 is not met**.\n    The acceleration factor is $\\exp(0.5625 \\times 1.5) = \\exp(0.84375) \\approx 2.32$. This is less than the required $3$-fold acceleration.\n2.  **Catalytic Efficiency**: $k_{\\mathrm{cat}}$ and $K_M$ are unchanged, but $K_d^{\\mathrm{B}} = 1.0 \\times 10^{-6}\\,\\mathrm{M}$. We must calculate the new dimer fraction $f_{\\mathrm{D,sub}}^{\\mathrm{B}}$.\n    $$f_{\\mathrm{D,sub}}^{\\mathrm{B}} = \\frac{(4(5.0 \\times 10^{-6}) + 1.0 \\times 10^{-6}) - \\sqrt{8(5.0 \\times 10^{-6})(1.0 \\times 10^{-6}) + (1.0 \\times 10^{-6})^2}}{4(5.0 \\times 10^{-6})}$$\n    $$f_{\\mathrm{D,sub}}^{\\mathrm{B}} = \\frac{2.1 \\times 10^{-5} - \\sqrt{4.0 \\times 10^{-11} + 1.0 \\times 10^{-12}}}{2.0 \\times 10^{-5}} = \\frac{2.1 \\times 10^{-5} - \\sqrt{4.1 \\times 10^{-11}}}{2.0 \\times 10^{-5}}$$\n    $$f_{\\mathrm{D,sub}}^{\\mathrm{B}} = \\frac{2.1 \\times 10^{-5} - 6.403 \\times 10^{-6}}{2.0 \\times 10^{-5}} \\approx \\frac{1.4597 \\times 10^{-5}}{2.0 \\times 10^{-5}} \\approx 0.7299$$\n    The overall efficiency retention is $1.0 \\times (f_{\\mathrm{D,sub}}^{\\mathrm{B}}/f_{\\mathrm{D,sub}}^{\\mathrm{WT}}) = 0.7299 / 0.9689 \\approx 0.753$. Since $0.753  0.8$, **Criterion 2 is not met**.\n**Verdict for B**: **Incorrect**. This option fails to meet both criteria.\n\n**Option C: K→A x2 in presequence**\n1.  **Import Acceleration**: $\\Delta\\Delta G_{\\mathrm{fold}} \\approx 0$. This provides no change in the unfolding rate, so the acceleration factor is $1$. **Criterion 1 is not met**. Furthermore, neutralizing positive charges in the presequence is stated to reduce the TIM23 translocation component, which would likely slow down, not accelerate, import.\n2.  **Catalytic Efficiency**: All relevant parameters ($k_{\\mathrm{cat}}, K_M, K_d$) are unaffected. The efficiency retention is $1.0$. **Criterion 2 is met**.\n**Verdict for C**: **Incorrect**. This option fails to provide the required import acceleration.\n\n**Option D: L→G in an active-site loop**\n1.  **Import Acceleration**: $\\Delta\\Delta G_{\\mathrm{fold}} = +2.0\\,\\mathrm{kcal\\,mol^{-1}}$. Since $2.0 > 1.953$, **Criterion 1 is met**.\n    The acceleration factor is $\\exp(0.5625 \\times 2.0) = \\exp(1.125) \\approx 3.08$. This achieves the required $3$-fold acceleration.\n2.  **Catalytic Efficiency**: $K_M$ increases $5$-fold, while other parameters are unchanged.\n    The ratio of enzymatic efficiencies is $(k_{\\mathrm{cat}}^{\\mathrm{D}}/K_M^{\\mathrm{D}}) / (k_{\\mathrm{cat}}^{\\mathrm{WT}}/K_M^{\\mathrm{WT}}) = 1/5 = 0.2$.\n    Since $K_d$ is unchanged, $f_{\\mathrm{D,sub}}^{\\mathrm{D}} = f_{\\mathrm{D,sub}}^{\\mathrm{WT}}$.\n    The overall efficiency retention is $0.2 \\times 1.0 = 0.2$. Since $0.2  0.8$, **Criterion 2 is not met**. The catalytic performance is drastically reduced.\n**Verdict for D**: **Incorrect**. Although import is accelerated, the enzyme becomes catalytically inefficient.\n\nBased on this rigorous analysis, only option A successfully meets both design criteria. It provides a substantial acceleration of import (over $5$-fold) while maintaining $90\\%$ of the wild-type catalytic efficiency. All other options fail on at least one of the two criteria. Therefore, option A is the only correct choice.", "answer": "$$\\boxed{A}$$", "id": "2960698"}, {"introduction": "Molecular defects rarely exist in isolation; they trigger complex, system-wide cellular responses. This final practice problem broadens the scope from a single protein to the entire cellular ecosystem [@problem_id:2960652]. Starting with a specific patient-derived mutation that impairs the import machinery, you will predict the cascade of downstream consequences, from the accumulation of precursor proteins to the activation of cellular stress and quality control pathways like mitophagy. This exercise hones your ability to think like a systems biologist, connecting a primary molecular lesion to a complex cellular phenotype.", "problem": "A patient-derived fibroblast line carries a missense mutation in the Translocase of the Inner Membrane subunit Tim50 that specifically reduces its binding affinity for mitochondrial presequences by $5$-fold, without directly altering the Translocase of the Outer Membrane (TOM) complex or the membrane potential across the inner mitochondrial membrane at the outset. Consider import via the canonical presequence pathway that uses the Translocase of the Inner Membrane complex Tim23, with Tim50 acting as an intermembrane space receptor, and with import energetics driven by the mitochondrial membrane potential $\\Delta \\psi$ and the adenosine triphosphate (ATP)-powered presequence translocase-associated motor (PAM) that includes mitochondrial heat shock protein 70 (mtHsp70). Use the following well-established facts as your fundamental base: (i) presequence-containing proteins are synthesized in the cytosol and post-translationally imported through the Translocase of the Outer Membrane (TOM) and Tim23 complexes; (ii) presequences are positively charged amphipathic helices whose translocation across the inner membrane is electrophoretically favored by $\\Delta \\psi$; (iii) Tim50 binds incoming presequences in the intermembrane space and coordinates channel opening with Tim23; (iv) a binding step with dissociation constant $K_d$ exhibits fractional occupancy $\\theta = \\dfrac{[L]}{[L] + K_d}$ at ligand concentration $[L]$.\n\nWhich of the following cellular phenotypes and compensatory adaptations are most consistent with the $5$-fold reduction in presequence binding affinity at Tim50? Select all that apply.\n\nA. Reduced steady-state import of matrix-targeted, presequence-containing proteins with accumulation of their precursors in the cytosol, triggering a mitochondrial precursor stress response that upregulates cytosolic chaperones and the proteasome.\n\nB. Baseline upregulation of respiratory flux to elevate $\\Delta \\psi$ in order to improve electrophoretic driving of presequences across the inner membrane, resulting in increased sensitivity to mild uncouplers and respiratory chain inhibitors.\n\nC. Rapid rerouting of presequence clients to the Translocase of the Inner Membrane 22 (TIM22) carrier pathway by rewiring targeting signals, restoring efficient import of those clients within the timescale of cell culture adaptation.\n\nD. Enhanced stabilization of PTEN-induced kinase $1$ (PINK$1$) on the outer membrane due to impaired import, promoting Parkin recruitment and increased mitophagy, especially under metabolic stress, with a trend toward a fragmented mitochondrial network.\n\nE. Upregulation of the Translocon at the Outer/Inner envelope membrane of Chloroplasts (Toc/Tic) as a cross-organelle compensatory mechanism to import mitochondrial precursors into chloroplasts.\n\nF. Partial compensation by increasing the abundance of Translocase of the Outer Membrane receptors Tom$20$/Tom$22$, overexpressing Tim50 and other Tim23 complex subunits to increase effective capture via mass action, and elevating components of the presequence translocase-associated motor (PAM), including mtHsp70, to improve the pulling force on engaged polypeptides.\n\nG. Accumulation of mitochondrial DNA-encoded proteins as non-imported precursors in the cytosol due to the Tim50 mutation.", "solution": "The user has provided a problem in molecular and cell biology concerning the consequences of a specific mutation in a mitochondrial protein import component. My task is to first validate the problem statement and then, if valid, to derive the correct answer by evaluating each option.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\n*   **Cell Line:** Patient-derived fibroblast line.\n*   **Mutation:** A missense mutation in the Translocase of the Inner Membrane subunit `Tim50`.\n*   **Biochemical Effect:** The mutation reduces the binding affinity of `Tim50` for mitochondrial presequences by a factor of $5$.\n*   **Explicitly Unaffected (at the outset):** The Translocase of the Outer Membrane (TOM) complex and the mitochondrial membrane potential ($\\Delta \\psi$).\n*   **Pathway Context:** Canonical presequence pathway involving the `Tim23` complex, with `Tim50` as an intermembrane space (IMS) receptor.\n*   **Energetics:** Import is driven by $\\Delta \\psi$ and the ATP-dependent presequence translocase-associated motor (PAM), which includes mitochondrial heat shock protein 70 (mtHsp70).\n*   **Provided Facts/Axioms:**\n    *   (i) Presequence-containing proteins are synthesized in the cytosol and imported post-translationally through the TOM and `Tim23` complexes.\n    *   (ii) Presequences are positively charged amphipathic helices, and their translocation is electrophoretically driven by $\\Delta \\psi$.\n    *   (iii) `Tim50` binds incoming presequences in the IMS and coordinates `Tim23` channel opening.\n    *   (iv) For a binding step with dissociation constant $K_d$, the fractional occupancy is $\\theta = \\dfrac{[L]}{[L] + K_d}$ where $[L]$ is the ligand concentration.\n\n**Step 2: Validate Using Extracted Givens**\n\nThe problem statement describes a realistic scenario in cell biology. The components mentioned (`Tim50`, `Tim23`, TOM, PAM, mtHsp70) and their described roles in the mitochondrial protein import pathway are consistent with established scientific knowledge. The specified mutation, a missense mutation altering binding affinity, is a common type of genetic defect. The quantitative effect (a $5$-fold reduction in affinity) provides a concrete basis for analysis. The relationship between binding affinity, the dissociation constant $K_d$, and fractional occupancy $\\theta$ is a fundamental concept from physical chemistry, correctly stated and applied to a biological context. The problem is scientifically grounded, well-posed, objective, and self-contained. It does not violate any of the criteria for invalidity.\n\n**Step 3: Verdict and Action**\n\nThe problem is valid. I will proceed with the solution.\n\n### Derivation and Option Analysis\n\nThe primary defect is a $5$-fold reduction in binding affinity of `Tim50` for presequences. Affinity is inversely proportional to the dissociation constant, $K_d$. Therefore, the mutation causes a $5$-fold increase in $K_d$:\n$$K_{d, \\text{mutant}} = 5 \\cdot K_{d, \\text{wild-type}}$$\nAccording to the provided fact (iv), the fractional occupancy of `Tim50` by a presequence (ligand, $[L]$) is:\n$$\\theta = \\dfrac{[L]}{[L] + K_d}$$\nThe mutation thus reduces the fractional occupancy of `Tim50` for any given concentration of presequence in the intermembrane space. Since `Tim50` binding is a necessary step for `Tim23` channel activity (fact iii), this reduction in binding events per unit time will lead to a decreased overall rate of protein import into the mitochondrial matrix for proteins that use this pathway. This constitutes a bottleneck in the import process.\n\nBased on this primary consequence, I will now evaluate each option.\n\n**A. Reduced steady-state import of matrix-targeted, presequence-containing proteins with accumulation of their precursors in the cytosol, triggering a mitochondrial precursor stress response that upregulates cytosolic chaperones and the proteasome.**\n\nThe reduced import rate, as derived above, will cause proteins destined for the mitochondria to accumulate in the cytosol where they are synthesized. This accumulation of non-imported mitochondrial precursors is a specific cellular stress known as mitochondrial precursor over-accumulation stress (mPOS). The cell responds to this stress by upregulating quality control machinery, including cytosolic chaperones (to keep the precursors soluble and prevent aggregation) and the ubiquitin-proteasome system (to degrade the excess precursors). This is a well-documented and logical chain of events.\n**Verdict:** Correct.\n\n**B. Baseline upregulation of respiratory flux to elevate $\\Delta \\psi$ in order to improve electrophoretic driving of presequences across the inner membrane, resulting in increased sensitivity to mild uncouplers and respiratory chain inhibitors.**\n\nImport is driven by two main forces: the receptor binding (`Tim50`) and the electrophoretic pull from $\\Delta \\psi$. A defect in one component can be partially compensated for by enhancing another. Increasing $\\Delta \\psi$ would increase the electrical driving force on the positively charged presequence (fact ii), potentially accelerating its translocation once the `Tim23` channel is engaged, thereby partially offsetting the reduced frequency of engagement. To increase $\\Delta \\psi$, the cell must increase the rate of proton pumping by the electron transport chain, which means increasing respiratory flux. A cell operating at a higher baseline respiratory rate has a lower respiratory reserve capacity. Consequently, it would be more vulnerable to metabolic insults like uncouplers (which dissipate $\\Delta \\psi$) or respiratory chain inhibitors, as these would more quickly push the cell below the bioenergetic threshold required for survival. The problem's caveat that $\\Delta \\psi$ is normal \"at the outset\" allows for this type of adaptive response over time.\n**Verdict:** Correct.\n\n**C. Rapid rerouting of presequence clients to the Translocase of the Inner Membrane 22 (TIM22) carrier pathway by rewiring targeting signals, restoring efficient import of those clients within the timescale of cell culture adaptation.**\n\nThe `TIM22` pathway imports a different class of proteins (multi-pass inner membrane proteins) which use different targeting signals (internal, non-cleavable signals) compared to the N-terminal presequences of `TIM23` substrates. \"Rewiring targeting signals\" would necessitate changing the amino acid sequences of hundreds of different proteins, which requires coordinated mutations in their respective genes. Such a genetic overhaul is not a mechanism that can occur on the \"timescale of cell culture adaptation,\" which is governed by plastic changes in gene expression and protein function, not large-scale evolution of protein-coding sequences. This option is mechanistically and temporally implausible.\n**Verdict:** Incorrect.\n\n**D. Enhanced stabilization of PTEN-induced kinase $1$ (PINK$1$) on the outer membrane due to impaired import, promoting Parkin recruitment and increased mitophagy, especially under metabolic stress, with a trend toward a fragmented mitochondrial network.**\n\nThe kinase `PINK1` is itself a substrate for the `TOM`/`TIM23` import pathway. In healthy mitochondria with a robust import capacity, `PINK1` is continuously imported and degraded. A defect in the `TIM23` machinery, as caused by the faulty `Tim50`, will impair `PINK1` import. This leads to the accumulation and stabilization of `PINK1` on the outer mitochondrial membrane. Stabilized `PINK1` initiates a signaling cascade that recruits the E3 ubiquitin ligase Parkin, leading to the ubiquitination of outer membrane proteins and subsequent degradation of the entire dysfunctional organelle via autophagy (mitophagy). This quality control mechanism is often associated with a fragmented mitochondrial morphology and is exacerbated by metabolic stress. The described phenotype is a direct and well-established consequence of compromised `TIM23`-dependent import.\n**Verdict:** Correct.\n\n**E. Upregulation of the Translocon at the Outer/Inner envelope membrane of Chloroplasts (Toc/Tic) as a cross-organelle compensatory mechanism to import mitochondrial precursors into chloroplasts.**\n\nThe problem specifies a \"patient-derived fibroblast line\". Fibroblasts are animal cells. Animal cells do not contain chloroplasts. Chloroplasts and their associated protein import machinery (`Toc`/`Tic`) are found in plants and algae. This option is biologically impossible for the given system.\n**Verdict:** Incorrect.\n\n**F. Partial compensation by increasing the abundance of Translocase of the Outer Membrane receptors Tom$20$/Tom$22$, overexpressing Tim50 and other Tim23 complex subunits to increase effective capture via mass action, and elevating components of the presequence translocase-associated motor (PAM), including mtHsp$70$, to improve the pulling force on engaged polypeptides.**\n\nThis option describes a compensatory upregulation of the components of the affected pathway. This is a classic cellular stress response governed by the principle of mass action.\n1.  **Upregulating `Tom20`/`Tom22`:** Increases the concentration of precursors at the import site, effectively increasing the local $[L]$ for `Tim50`.\n2.  **Overexpressing `Tim50` and `Tim23` subunits:** Even if the mutant `Tim50` has a lower affinity, increasing its total concentration ($[Tim50]_{total}$) would increase the absolute number of productive binding events ($[Tim50 \\cdot Presequence] \\propto \\theta \\cdot [Tim50]_{total}$).\n3.  **Elevating PAM components:** The PAM motor acts as an ATP-driven ratchet, pulling the protein into the matrix. Strengthening this motor makes translocation more processive and less reversible, which can help \"lock in\" the protein after a transient and less stable binding event at `Tim50`.\nThese coordinated upregulations are characteristic of the mitochondrial unfolded protein response (UPR$^{mt}$), a known adaptive program to cope with mitochondrial proteostasis stress.\n**Verdict:** Correct.\n\n**G. Accumulation of mitochondrial DNA-encoded proteins as non-imported precursors in the cytosol due to the Tim50 mutation.**\n\nProteins encoded by the mitochondrial DNA (mtDNA) are synthesized on mitoribosomes located within the mitochondrial matrix. They are not synthesized in the cytosol and are not imported into the mitochondrion. Therefore, they are not substrates for the `TOM`/`TIM23` pathway and are unaffected by the `Tim50` mutation. The premise that these proteins could accumulate as \"non-imported precursors in the cytosol\" is fundamentally incorrect based on the location of their synthesis.\n**Verdict:** Incorrect.\n\nFinal summary of correct options: A, B, D, F.", "answer": "$$\\boxed{ABDF}$$", "id": "2960652"}]}